New analysis boosts drug's prostate cancer value (Reuters)

[riky]

New analysis boosts drug's prostate cancer value
    (Reuters)

 


Reuters - A new analysis of data from a key
prostate cancer study has strengthened the view that a drug
that is now sold as a generic may be a valuable weapon to
prevent prostate cancer, researchers said on Monday.


You are not allowed to view links. Register or Login/news.yahoo.com/s/nm/20080519/hl_nm/prostate_drug_dc